Upm Pharmaceuticals Inc Baltimore, MD - 21224

Upm Pharmaceuticals Inc is categorized under Commercial Medical Research in Baltimore, MD and active since 1997.

Upm Pharmaceuticals Inc was established in 1997, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact John M Gregory at the company’s headquarters by writing to 6200 Seaforth St # 1, Baltimore, Maryland MD 21224 or by phoning (410) 843-3700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Upm Pharmaceuticals Inc
Contact Person: John M Gregory
Address: 6200 Seaforth St # 1, Baltimore, Maryland 21224
Phone Number: (410) 843-3700
Website Address: upm-inc.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1997
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Upm Pharmaceuticals Inc was started in 1997 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact John M Gregory for inquiries that concern Upm Pharmaceuticals Inc by calling the company number (410) 843-3700, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Upm Pharmaceuticals Inc can be found at the coordinates 39.270867,-76.540308 as well as the street address 6200 Seaforth St # 1 in Baltimore, Maryland 21224.

For its online presence, you may visit Upm Pharmaceuticals Inc’s website at upm-inc.com and engage with its social media outlets through on Twitter and on Facebook.